Tishreen University - faculty of Dentistry
Latakia, Syria
NCT Number: NCT07103421
Study the effect of non-surgical periodontal therapy on cystatin C levels in gingival crevicular fluid and serum in both healthy patients and patients with renal impairment. The number of participants is 30 individuals, divided into three groups receiving conservative periodontal treatment (scaling and root planing):Systemically and periodontally healthy patients, Patients with periodontitis without systemic diseases, and Patients with periodontitis and chronic kidney disease. The study also aims to determine the relationship between the severity of periodontal disease and kidney function by measuring cystatin C levels, which is an important biomarker for both conditions. Additionally, it seeks to assess whether non-surgical periodontal therapy can be included in the treatment protocols for kidney patients to improve their quality of life.
Looking for future studies?
Notify Me20 year–70 year
All sexes
Interventional
Not applicable
Latakia, Syria
Periodontal diseases, particularly gingivitis and periodontitis, are common inflammatory conditions affecting the tooth-supporting tissues. These diseases induce both local and systemic inflammatory responses, which may impact other organs, including the kidneys. Cystatin C (CSTC) is an inhibitor of cysteine proteases and is considered an important biomarker for kidney function, as its serum levels rise in cases of renal impairment. Periodontal diseases may contribute to elevated serum cystatin C levels due to systemic inflammation caused by bacterial infection and inflammatory mediators circulating in the bloodstream. On the other hand, non-surgical periodontal therapy (e.g., scaling and root planing) may reduce both local and systemic inflammation, potentially improving cystatin C levels and kidney function. This study aims to: Assess and compare cystatin C levels in serum and gingival crevicular fluid (GCF) among healthy individuals and patients with periodontitis، Examine the effect of non-surgical periodontal therapy on serum and GCF cystatin C levels in patients with renal impairment compared to healthy controls، and Analyze the relationship between periodontitis severity and kidney function by correlating cystatin C levels with other renal markers (e.g., glomerular filtration rate).
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
For Chronic Kidney Disease (CKD) Patients:
Exclusion criteria
Non-surgical periodontal therapy involves the removal of bacterial plaque and calculus from tooth surfaces and root surfaces beneath the gum line using manual or ultrasonic instruments. This treatment is performed for patients with periodontitis to improve gum health and reduce inflammation. Serum cystatin C levels will be compared before and after treatment between healthy patients and those with renal impairment.
Time frame: Baseline (before treatment) and 4 weeks after completion of periodontal therapy
Comparison of serum Cystatin C concentration (mg/L) between baseline and 4 weeks post non-surgical periodontal treatment (scaling and root planing) in periodontitis patients with and without chronic kidney disease.
Time frame: Baseline measurement (pre-treatment) and 4 weeks post-treatment completion
Measurement of changes in clinical periodontal parameters (clinical attachment level CAL) at 4 sites per tooth, 4 weeks after non-surgical periodontal therapy (scaling and root planing) in systemically healthy periodontitis patients.
Time frame: Baseline measurement (pre-treatment) and 4 weeks follow-up
Measurement of changes in OHI-s (Oral Hygiene Index simplified) to assess oral health-related quality of life before and after periodontal therapy across all study groups.
Time frame: Baseline measurement (pre-treatment) and 4 weeks post-treatment completion
Evaluation of changes in serum cystatin C levels in chronic kidney disease patients (stages 1-3) 4 weeks after non-surgical periodontal therapy.
Latakia University
Other
Effect of Non-Surgical Periodontal Therapy on Cystatin C Levels in Healthy and Renal Impaired Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02114281
Chronic Disease, Chronic Kidney Disease
Bordeaux, France
View Trial DetailsNCT01217281
Chronic Disease, Chronic Kidney Disease
Athens, Greece
View Trial DetailsNCT06578832
Caries,Dental, Chronic Disease
Istanbul, Maltepe, Turkey (Türkiye)
View Trial DetailsNCT01094639
Chronic Disease, Chronic Kidney Disease
Farmington, Connecticut, United States
View Trial Details